Structure Therapeutics (formerly known as ShouTi) is a company that develops drugs for patients using computational and structure-based technology. It offers a platform that combines the visualization of receptor-binding interactions with the simulation of molecular motion and signal transduction to design molecules with binding properties and confirmational characteristics. The company is focused on developing medicine for chronic diseases including cardiovascular, metabolic, and pulmonary conditions.